See also this year's filing and all EDGAR filings for this company.
PDF Report 0000875320_2025_Vertex_Pharmaceuticals_INC_MA.pdf
Logs
Graph
Absolute values for 0000875320, Vertex Pharmaceuticals INC MA
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 9,596,400,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,913,900,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 11,022,900,000 |
| 4 | LiabilitiesCurrent | 3,564,600,000 |
| 5 | LiabilitiesNoncurrent | 2,446,200,000 |
| 6 | remainder_Liabilities | 112,800,000 |
| 7 | CostOfGoodsAndServicesSold | 2,076,339,221 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,854,812,698 |
| 9 | ResearchAndDevelopmentExpense | 30,963,244,912 |
| 10 | remainder_Expenses | 778,347,360 |
| 11 | remainder_Revenues | 14,413,347,780 |
| 12 | remainder_NetIncome | 512,884,246 |
| 13 | remainder_ComprehensiveNetIncome | 78,781,740 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 22,533,200,000 |
| 1 | Liabilities | 6,123,600,000 |
| 2 | Expenses | 36,672,744,191 |
| 3 | Revenues | 14,413,347,780 |
| 4 | StockholdersEquity | 16,409,600,000 |
| 5 | NetIncome | -21,746,512,165 |
| 6 | ComprehensiveNetIncome | -21,707,121,295 |
| 7 | BaseVar | 40,167,278,978 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.982 |
| 9 | EconomicCapitalRatio | 2.29 |
Edgar->Model Mapping
Feature Distribution
Change over Time
